化学
药理学
药物发现
G蛋白偶联受体
精神分裂症(面向对象编程)
神经科学
受体
医学
生物化学
心理学
精神科
作者
Yingzhi Bi,Carolyn D. Dzierba,Cynthia A. Fink,Yudith Garcia,Michael Green,Jianxin Han,Soojin Kwon,Godwin Kumi,Zhi Liang,Ying Liu,Ying Qiao,Yulian Zhang,Greg Zipp,Neil T. Burford,Meredith Ferrante,Robert Bertekap,Martin Lewis,Angela Cacace,Ryan S. Westphal,David B. Kimball,Joanne J. Bronson,John E. Macor
标识
DOI:10.1016/j.bmcl.2015.02.038
摘要
Modulating GPR88 activity is suggested to have therapeutic utility in the treatment of CNS disorders, such as schizophrenia. This Letter will describe the discovery and SAR development of a class of potent GPR88 agonists.
科研通智能强力驱动
Strongly Powered by AbleSci AI